Association of STEMI regionalization of care with de facto NSTEMI regionalization - 30/10/21
Doi : 10.1016/j.ahj.2021.07.002
Juan Carlos C. Montoy, MD, PhD a, ⁎ 
, Yu-Chu Shen, PhD b, Harlan M Krumholz, MD, SM c, d, e, Renee Y. Hsia, MD, MSc a, f
, Yu-Chu Shen, PhD b, Harlan M Krumholz, MD, SM c, d, e, Renee Y. Hsia, MD, MSc a, f a Department of Emergency Medicine, University of California, San Francisco
b Naval Postgraduate School
c Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine
d Department of Health Policy and Management, Yale School of Public Health
e Center for Outcomes Research and Evaluation, Yale–New Haven Hospital
f Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco
⁎Reprint requests: Juan Carlos C. Montoy, MD, PhD, University of California, San Francisco, Department of Emergency Medicine, 1001 Potrero Ave, Bldg 5, Rm 6A, San Francisco, CA, 94110University of California, San FranciscoDepartment of Emergency Medicine1001 Potrero Ave, Bldg 5, Rm 6ASan FranciscoCA94110
Résumé |
The regionalization of care for ST elevation myocardial infarction (STEMI) may unintentionally concentrate patients with non-ST elevation myocardial infarction (NSTEMI) into percutaneous coronary intervention (PCI) capable hospitals. This could lead to benefits such as increased access to PCI-capable hospitals, but could cause harms such as crowding in some hospitals with decreased patient volume and revenue in others. We set out to assess whether STEMI regionalization programs concentrated patients with NSTEMI at STEMI-receiving hospitals.
Le texte complet de cet article est disponible en PDF.Plan
© 2021
Elsevier Inc. Tous droits réservés.
Vol 242
P. 1-5 - décembre 2021 Retour au numéro
Article précédent
- Patient evaluation of a virtual visit program for adults with congenital heart disease
- Yamini Krishnamurthy, Jaclyn A. Pagliaro, Connor B. Grady, Nava Katz, David Bunn, Ami B. Bhatt
- Performance of the ESC 0/2h-algorithm using high-sensitivity cardiac troponin I in the early diagnosis of myocardial infarction
- Luca Koechlin, Jasper Boeddinghaus, Thomas Nestelberger, Pedro Lopez-Ayala, Desiree Wussler, Samyut Shrestha, Tobias Resa, Karin Wildi, Adam Bakula, Simon Frey, Òscar Miró, F Javier Martin-Sanchez, Ivo Strebel, Danielle M Gualandro, Friedrich S Eckstein, Oliver Reuthebuch, Dagmar I Keller, Raphael Twerenbold, Maria Rubini Giménez, Christian Mueller, for the APACE investigators, Tobias Zimmermann, Tobias Reichlin, Michael Christ, Christian Puelacher, Jeanne du Fay de Lavallaz, Eliska Potlukova, Matthias Diebold, Damian Kawecki, Nicolas Geigy, Katharina Rentsch, Sandra Mitrovic, Carolina Fuenzalida, Noemi Glarner, Beata Morawiec, Piotr Munzk, Tobias Breidthardt, Michael Freese, Beatriz López, Sofia Calderón, Esther Rodriguez Adrada, Eva Ganovská, Jiri Parenica, Arnold von Eckardstein, Isabel Campodarve, Joaquim Gea
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?